Beta Blocker Tolerability and Efficacy

Introduction to Beta Blocker Therapy

• The European Society of Cardiology recommends bisoprolol, carvedilol, and metoprolol succinate for heart failure patients due to their proven mortality benefits 1, 2
• The American College of Cardiology suggests that beta blockers with high cardioselectivity, such as bisoprolol, are preferred in patients with diabetes to minimize effects on glucose metabolism 5

Special Populations and Tolerability Considerations

• The European Respiratory Society notes that bisoprolol is the only beta blocker not contraindicated in chronic obstructive pulmonary disease (COPD) due to its high β1-selectivity 3
• The American College of Cardiology recommends that all beta blockers are contraindicated in asthma with positive bronchoreactivity 3
• The European Association for the Study of Diabetes suggests that carvedilol may have favorable effects on insulin resistance but is less cardioselective 5

Practical Approach to Maximize Tolerability

• The American College of Cardiology recommends starting with a low dose and titrating gradually (no more frequently than every 2 weeks) to maximize tolerability 1, 6
• The European Society of Cardiology advises aiming for target dose or highest tolerated dose, and monitoring heart rate, blood pressure, and clinical status during titration 1, 6
• The American Heart Association notes that temporary symptomatic deterioration may occur in 20-30% of cases during initiation/up-titration phase 1